Share Name Share Symbol Market Type Share ISIN Share Description
Omega Dia LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 18.25p 18.00p 18.50p 18.375p 18.25p 18.25p 255,015.00 13:00:50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 12.7 0.7 0.5 36.5 19.85

Omega Diagnostics Share Discussion Threads

Showing 1526 to 1549 of 1550 messages
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older
DateSubjectAuthorDiscuss
27/2/2017
13:25
LOL Barry.This explains some of the recent trades, but it is clear too that our Mr Sneller doesn't like overpaying and has been picking up loose stock only as and when it comes available.But yes - it is good to have a fund manager continuously acquiring stock for his own personal account. Surprised it hasn't encouraged some other funds to think about taking a punt - but given the lowly market cap - perhaps it is not too unsurprising.
longshanks
27/2/2017
13:19
Yep - he's bought another 1.25m shares since November and is above 11% now. Shame really. Without him I suspect we'd have been able to buy shedloads at 16p or even less :o((
rivaldo
17/2/2017
15:40
Moves fast when it wants to....
longshanks
17/2/2017
11:04
Buyers will come...We just need the catalyst for them to see this as more than just a tired, low-growth med-tech stock. It will happen, but when, oh when.Come on ODX - strut your stuff.
longshanks
17/2/2017
10:51
Hi Leeds, unfortunately mate there is only a handful of Investors that are prepared to buy at the moment, so when we have a seller we don't have sufficient buyers to take up the sells....but hopefully getting near to some news on the IDH situation and an update on the Indian plant and CD4....
barrywhit
17/2/2017
09:08
Bought another 8k worth last couple days did not imagine getting them at this price again
leedslad001
14/2/2017
17:18
Strange trading lately, now 2 x 500k trades showing late.......
barrywhit
07/2/2017
18:12
Someone bought a nice chunk today at a pretty premium - hence the retrace on the bid price.ODX appear to have a large team out in Dubai for the medlab series event. HTTp://www.medlabseries.comHopefully plenty of sales developing for Allersys.
longshanks
03/2/2017
14:39
....are we on our way?The trading pattern has developed a very tight pennant over the last 3-6 months which mirror a larger pennant covering the last 3 years. We could easily see a break-out from here.
longshanks
02/2/2017
14:14
Thanks for that Rivaldo, not that surprising though bearing in mind that L&G hold 12.88% of ODX and have been onboard for over 6 years now, they must be as keen as we all are to see a bit of share action :o)
hyperboreus
02/2/2017
13:42
FYI, at Tuesday's Cenkos Growth Company Show, Richard Penny (senior fund manager at L&G UK Alpha Trust) noted ODX as one of his favoured investment ideas under the Medical Device category in his presentation.
rivaldo
31/1/2017
19:13
a lot changing hands again.....
barrywhit
27/1/2017
17:21
I am guessing that the 100k trade (just announce) filled at 17.63 is a buy.
longshanks
27/1/2017
16:12
Just been quoted 17.785p to sell 80k, so it looks like they are hunting for shares...
barrywhit
27/1/2017
13:02
I was quoted 17.6 to sell in quantity this morning so given it was at 8:45 I think it was a sell.I agree with dibs though; looks well bid
longshanks
27/1/2017
12:19
I would think the 155k trade was a buy.....
barrywhit
27/1/2017
11:59
I wonder if the delayed sell 155294@ 17.6 is the tale end of the offloading. Now that the IDH situation has been clarified it also frees our BoD, should they be in the mood, to fill their boots.
longshanks
27/1/2017
11:54
Yep def barry. What's puzzling me is the bid is up and large trade 155k for 17.6 but no sign of any buys? Anyone got sight of L2? What's the order book look like? There must be a large one out there being filled? Sneller again?
dibs61
27/1/2017
11:21
Dibs, Thanks and yes I know the Enterprise grant was to help fund the expansion of the Allersys range which was a great help, but if IDH also help with the cost it will free up funds for the ongoing CD4 costs....just a thought....
barrywhit
27/1/2017
10:52
Barry - the RNS 2.8.2016 stated: "Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has secured a Scottish Enterprise research and development grant of £1.8 million. The R&D grant represents a significant contribution towards the total R&D project costs to fund the planned expansion of the Company's Allersys® range of reagent" So this will cover a significant portion of the total cost. Perhaps the remainder will be covered by internal resources or a small part of a future fundraising?
dibs61
27/1/2017
09:21
My concern is more working capital. They need cash to finance CD4 roll-out when it happens and whilst the payback will be rapid, cash flow will be a problem.Anyway, going by his twitter feed, the sales director is still travelling extensively to far-flung parts of the world so I guess cash is not yet that tight!
longshanks
27/1/2017
08:37
Perhaps IDH will help fund the enlarged allergy tests as ODX were looking to increase from the 41 already CE marked to I think they stated 120..... as cash will be required for the expansion....
barrywhit
27/1/2017
07:59
ODX do need cash and I wouldn't be surprised if a fundraising happens if the discussions with iDH don't involve any upfront cash. I am sure the business can also support some debt now and as we are at a discount to NAV that may be a better option.
longshanks
27/1/2017
07:42
Might it mean cash needed if no injection from elsewhere? It is a vote of confidence.
p1nkfish
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170227 13:44:26